IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cosciens Biopharma Inc (CSCIF)

CUSIP: 22112H101 | NYSE | Healthcare · Biotechnology | Micro Cap | 21 institutional holders

Quarters

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/APuccetti Funds Management Inc.15,6870.5%Newly reportedMar 1, 2026No 13F filer matched
13D/APuccetti Funds Management Inc.15,687

Institutional Holders — Q3 2025

TD Waterhouse Canada Inc.3,860
0.0% of portfolio›$10.2K
Osaic Holdings, Inc.50
0.0% of portfolio›$153
StyleTurnoverLocationFiled
TD Waterhouse Canada Inc.
3,860$10.2K0.0%CoreLowToronto, Australia2025-11-03
Osaic Holdings, Inc.
50$1530.0%IndexLowScottsdale, AZ2025-11-14
0.5% of class · Mar 1, 2026
Newly reported
No 13F filer matched